Karen Robards - BlackRock Science Independent Co-Chairman of the Board of Trustees
BST Etf | USD 34.08 0.02 0.06% |
Ms. Karen P. Robards is Independent Vice Chairman of the Board of Blackrock Science And Technology Trust . The Board benefits from Ms. Robards many years of experience in investment banking and the financial advisory industry where she obtained extensive knowledge of the capital markets and advised clients on corporate finance transactions, including mergers and acquisitions and the issuance of debt and equity securities. Ms. Robards prior position as an investment banker at Morgan Stanley provides useful oversight of the Trusts investment decisions and investment valuation processes. Additionally, Ms. Robards experience derived from formerly serving as a director of Care Investment Trust, Inc., a health care real estate investment trust, and currently serving as a director of Greenhill Co., Inc., an independent investment bank, provides the Board with the benefit of her experience with the management practices of other financial companies. Ms. Robards longstanding service on the boards of the ClosedEnd Complex also provides her with a specific understanding of the Trust, its operations, and the business and regulatory issues facing the Trust. Ms. Robards knowledge of financial and accounting matters qualifies her to serve as Vice Chair of the Board and as the Chair of the Trusts Audit Committee
Age | 71 |
Tenure | 7 years |
Phone | 212 810 5300 |
Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Karen Robards Latest Insider Activity
Tracking and analyzing the buying and selling activities of Karen Robards against BlackRock Science etf is an integral part of due diligence when investing in BlackRock Science. Karen Robards insider activity provides valuable insight into whether BlackRock Science is net buyers or sellers over its current business cycle. Note, BlackRock Science insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Science'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Karen Robards over a year ago Acquisition by Karen Robards of 161 shares of BlackRock Floating subject to Rule 16b-3 |
Similar Fund Executives
Found 14 records | One Year Return | ||
Jeremy May | Reaves Utility If | 49 | |
Joseph Harvey | Cohen Steers Total | 57 | |
Oleg Pohotsky | Tekla Healthcare Investors | 73 | |
Joseph Harvey | Cohen Steers Reit | 57 | |
Robert Steers | Cohen Steers Qualityome | 67 | |
Robert Steers | Cohen Steers Total | 67 | |
Deborah DeCotis | Pimco Corporate Income | 69 | |
William Park | Eaton Vance Enhanced | 74 | |
Catherine Paglia | Columbia Seligman Premium | 68 | |
Robert Steers | Cohen And Steers | 67 | |
Hans Kertess | Pimco Corporate Income | 82 | |
Jeremy Deems | Reaves Utility If | 43 | |
Richard Cavanagh | BlackRock Health Sciences | 75 | |
Robert Steers | Cohen Steers Reit | 67 |
BlackRock Science Tech Money Managers
Henry Gabbay, Independent Trustee | ||
Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
Frank Fabozzi, Independent Trustee | ||
J Holloman, Independent Trustee | ||
Janey Ahn, Secretary | ||
John Perlowski, President, Chief Executive Officer, Trustee | ||
Michael Castellano, Independent Trustee | ||
Cynthia Egan, Independent Trustee | ||
Jay Fife, Treasurer | ||
R Hubbard, Independent Trustee | ||
Jonathan Diorio, Vice President | ||
Robert Fairbairn, Trustee | ||
Neal Andrews, Chief Financial Officer | ||
Trent Walker, Chief Financial Officer | ||
Catherine Lynch, Independent Trustee | ||
Stayce Harris, Independent Trustee | ||
W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Shares Outstanding | 33.68 M | ||||
Shares Owned By Insiders | 0.01 % | ||||
Shares Owned By Institutions | 18.53 % | ||||
Number Of Shares Shorted | 14.74 K | ||||
Price To Earning | 5.78 X | ||||
Short Ratio | 0.09 X | ||||
Earnings Per Share | 5.41 X | ||||
Number Of Employees | 17 | ||||
Market Capitalization | 1 B | ||||
Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.